12 results match your criteria: "The Institute for Female Pelvic Medicine and Reconstructive Surgery[Affiliation]"
Female Pelvic Med Reconstr Surg
January 2021
From the Artann Laboratories, Trenton, NJ.
Objective: This study examined biomechanical changes in pelvic floor after urogynecological surgery.
Methods: This multisite clinical study was designed to explore changes in tissue elasticity, pelvic support, and certain functions (contractive strength, muscle relaxation speed, muscle motility) after pelvic organ prolapse (POP) surgery. A biomechanical mapping of the pelvic floor was performed before and 4 to 6 months after the surgery.
EC Gynaecol
November 2018
Princeton Urogynecology, Princeton, United States.
Introduction: Quantitative biomechanical characterization of pelvic supportive structures and functions in vivo is thought to provide insight into the pathophysiology of pelvic organ prolapse (POP). Vaginal tactile imaging is an innovative approach to the biomechanical mapping of the female pelvic floor to quantify tissue elasticity, pelvic support, and pelvic muscle functions. The Vaginal Tactile Imager (VTI) records high definition pressure patterns through the vaginal walls under an applied tissue deformation and during pelvic floor muscle contractions.
View Article and Find Full Text PDFAm J Obstet Gynecol
August 2018
Department of Obstetrics and Gynecology, University of Texas Southwestern, Dallas, TX.
Objective: We aimed to systematically review the literature on apical pelvic organ prolapse surgery with uterine preservation compared with prolapse surgeries including hysterectomy and provide evidence-based guidelines.
Data Sources: The sources for our data were MEDLINE, Cochrane, and clinicaltrials.gov databases from inception to January 2017.
Int Urogynecol J
October 2017
The Institute for Female Pelvic Medicine and Reconstructive Surgery, 3050 Hamilton Blvd, Suite 200, Allentown, PA, 18103, USA.
Int J Womens Health
August 2017
Artann Laboratories, Trenton, NJ, USA.
Obstet Gynecol
May 2017
University of New Mexico, Albuquerque, New Mexico; the University of Texas Southwestern Medical Center, Dallas, Texas; Women & Infants Hospital, Warren Alpert Medical School of Brown University, Providence, Rhode Island; the University of North Carolina, Chapel Hill, North Carolina; the University of Alabama at Birmingham, Birmingham, Alabama; ProHealth, Waukesha Memorial Hospital, Waukesha, Wisconsin; Columbia University Medical Center and Icahn School of Medicine at Mount Sinai, New York, New York; the Center for Evidence Based Medicine, Brown University School of Public Health, Providence, Rhode Island; and the Institute for Female Pelvic Medicine and Reconstructive Surgery, North Wales, Pennsylvania.
Obstet Gynecol
September 2016
University of Texas Health Science Center San Antonio, San Antonio, Texas; Women & Infants Hospital, Alpert Medical School of Brown University, and the Center for Evidence Based Medicine, Brown University, Providence, Rhode Island; Baylor College of Medicine, Houston, Texas; the University of California, San Diego, San Diego, California; Case Western Reserve University School of Medicine, Cleveland, Ohio; Carilion Clinic, Roanoke, Virginia; Columbia University, College of Physicians and Surgeons, New York, New York; the University of New Mexico, Albuquerque, New Mexico; the University of South Carolina School of Medicine, Greenville, South Carolina; and the Institute for Female Pelvic Medicine and Reconstructive Surgery, North Wales, Pennsylvania.
Objective: To compare the long-term risks associated with salpingo-oophorectomy with ovarian conservation at the time of benign hysterectomy.
Data Sources: MEDLINE, ClinicalTrials.gov, and the Cochrane Central Register of Controlled Trials were searched from inception to January 30, 2015.
Obstet Gynecol
July 2016
University of Michigan, Ann Arbor, Michigan; the University of Mississippi, Jackson, Mississippi; the University of Maryland School of Medicine, Baltimore, Maryland; Dell Medical School, the University of Texas at Austin, Austin, Texas; Rambam Health Care Campus, Technion Faculty of Medicine, Haifa, Israel; Vanderbilt University Medical Center, Nashville, Tennessee; Women and Infants' Hospital, the Warren Alpert Medical School of Brown University, and Brown University School of Public Health, Providence, Rhode Island; and the Institute for Female Pelvic Medicine and Reconstructive Surgery, North Wales, Pennsylvania.
Objective: To update clinical practice guidelines on graft and mesh use in transvaginal pelvic organ prolapse repair based on systematic review.
Data Sources: Eligible studies, published through April 2015, were retrieved through ClinicalTrials.gov, MEDLINE, and Cochrane databases and bibliography searches.
The purpose of the study was to determine the efficacy and safety of nonantimuscarinic treatments for overactive bladder. Medline, Cochrane, and other databases (inception to April 2, 2014) were used. We included any study design in which there were 2 arms and an n > 100, if at least 1 of the arms was a nonantimuscarinic therapy or any comparative trial, regardless of number, if at least 2 arms were nonantimuscarinic therapies for overactive bladder.
View Article and Find Full Text PDFObstet Gynecol
December 2014
University of Texas Southwestern Medical Center, Dallas, Texas; Women & Infants Hospital, Alpert Medical School of Brown University and the Center for Evidence Based Medicine, Brown University, Providence, Rhode Island; the University of Maryland School of Medicine, Baltimore, Maryland; the Icahn School of Medicine at Mount Sinai, New York, New York; Vanderbilt University Medical Center, Nashville, Tennessee; the University of New Mexico Health Sciences Center, Albuquerque, New Mexico; Henry Ford Health System, Detroit, Michigan; and the Institute for Female Pelvic Medicine and Reconstructive Surgery, North Wales, Pennsylvania.
Objective: To comprehensively review and critically assess the literature on vaginal estrogen and its alternatives for women with genitourinary syndrome of menopause and to provide clinical practice guidelines.
Data Sources: MEDLINE and Cochrane databases were searched from inception to April 2013. We included randomized controlled trials and prospective comparative studies.
Female Pelvic Med Reconstr Surg
November 2010
From the *Institute for Female Pelvic Medicine and Reconstructive Surgery, Allentown, PA; †Scott & White, Temple, TX; ‡Evanston Northshore Hospital, Evanston, IL; §University of Pennsylvania, Philadelphia, PA; ∥University of Texas Southwestern Medical Center, Dallas, TX; ¶University of New Mexico, Albuquerque, NM; #Brigham and Women's Hospital, Boston, MA; **Loyola University, Chicago, IL; and ††Greater Baltimore Medical Center, Baltimore, MD.
Objectives: : The purpose of this study was to determine outcomes of sling revision after midurethral sling (MUS) placement and whether timing of sling revision affected those outcomes.
Materials And Methods: : This is a multicenter study including patients who underwent MUS placement and subsequent sling revision secondary to voiding dysfunction. Diagnostic outcomes before and after sling revision were compared for all sling revision patients with complete data.
Female Pelvic Med Reconstr Surg
September 2010
From the *Institute for Female Pelvic Medicine and Reconstructive Surgery, North Wales; †Abington Memorial Hospital, Abington; and ‡St Luke's Hospital and Health Network, Allentown, PA.
Introduction: : Previous investigations have shown an increased risk of mesh erosion when concomitant vaginal hysterectomy is performed at the time of transvaginal reconstruction with mesh. We hypothesize that vaginal hysterectomy can be performed without a high risk of erosion.
Methods: : This is a retrospective, repeated-measures study of women with uterovaginal prolapse who underwent vaginal hysterectomy and pelvic reconstruction with a transvaginal mesh technique using the Prolift system.